pharma · Duchenne Muscular Dystrophy · Muscular Dystrophies · CAPR
CAPRICOR THERAPEUTICS
CAPRICOR THERAPEUTICS, INC.
CAPRICOR THERAPEUTICS trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
San Diego, USA HQ
2005 Founded
240 Employees
Public company Type
CAPR · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2005
- Employees
- 240
- Programs
- 8
- Drugs
- 6
- Patents
- 43
CAPRICOR THERAPEUTICS clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to CAPRICOR THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.
CAPRICOR THERAPEUTICS trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for CAPRICOR THERAPEUTICS.
-
CAP-1002 Allogeneic Cardiosphere-Derived Cells — Phase 2
Clinical update -
Allogeneic Cardiosphere-Derived Cells (CDCs) — Phase 1
Clinical update -
Allogeneic Cardiosphere-Derived Cells (CAP-1002) — Phase 2
Clinical update -
Deramiocel (CAP-1002) — Phase 3
Clinical update -
Deramiocel (CAP-1002) — Phase 2
Clinical update -
Cenderitide — Phase 2
Clinical update -
CAP-1002 — Phase 2
Clinical update -
CAP-1002 — Phase 2
Clinical update